IFNA1 and hepatocellular carcinoma: The scientific and clinical rationale being several retrospective studies [20][54] carried out in the late 1990’s showing that IFN therapy was associated with a reduction in the rates of HCC development as compared to clinical observation, as well as the well-known anti-proliferative effects of IFN on various cell lines.